Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / *W EXP 09/24/202
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
2,014,163
-
Shares change
-
-500,578
-
Total reported value, excl. options
-
$2,970,000
-
Value change
-
-$731,361
-
Number of buys
-
4
-
Number of sells
-
-13
-
Price
-
$1.47
Significant Holders of Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) as of Q4 2021
21 filings reported holding JSPRW - Jasper Therapeutics, Inc. - *W EXP 09/24/202 as of Q4 2021.
Jasper Therapeutics, Inc. - *W EXP 09/24/202 (JSPRW) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,014,163 shares
.
Largest 10 shareholders include HIGHBRIDGE CAPITAL MANAGEMENT LLC (561,448 shares), Owl Creek Asset Management, L.P. (374,833 shares), Ionic Capital Management LLC (338,676 shares), TENOR CAPITAL MANAGEMENT Co., L.P. (250,000 shares), Shaolin Capital Management LLC (128,572 shares), Privium Fund Management B.V. (98,011 shares), RIVERNORTH CAPITAL MANAGEMENT, LLC (65,707 shares), Integrity Capital Management (HK) Ltd (50,000 shares), EQUITEC PROPRIETARY MARKETS, LLC (45,856 shares), and HRT FINANCIAL LP (37,045 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.